| Title |
|
|
|
Therapeutic potential of nitric oxide donors in the prevention and treatment of atherosclerosis
| |
| Author |
|
|
|
| |
| Abstract |
|
|
|
| Well-known risk factors for atherosclerosis include hypercholesterolaemia, hypertension, diabetes, and smoking. These conditions are associated with endothelial dysfunction, which itself is associated with reduced endothelial generation of nitric oxide (NO). This is an overview of the implications of NO generation in atherosclerosis and of the potential therapeutic benefit of drugs which donate NO, such as organic nitrates, nicorandil, and sydnonimines, or those which increase the availability of endogenous NO, such as statins, angiotensin-converting enzyme inhibitors, L-arginine, and tetrahydrobiopterin. | | |
| Language |
|
|
|
English
| |
| Source (journal) |
|
|
|
European heart journal. - London | |
| Publication |
|
|
|
London : 2005
| |
| ISSN |
|
|
|
0195-668X [Print]
1522-9645 [Online]
| |
| Volume/pages |
|
|
|
26:19(2005), p. 1945-1955
| |
| ISI |
|
|
|
000232103200006
| |
| Full text (Publisher's DOI) |
|
|
| | |
| Full text (open access) |
|
|
| | |
|